CARB-X wins $370 Million to Fight Antibiotic Resistance
CARB-X, a nonprofit global partnership that channels funding and expertise to companies for new antibiotics, vaccines, and rapid diagnostics, is receiving up to $370 million in additional funding from the Biomedical Advanced Research and Development Authority (BARDA) and Wellcome, a global charitable foundation.
